Cytokinetics (CYTK) Earnings Date & Reports

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CYTK is expected to report earnings to fall 1.80% to -163 cents per share on July 30

Cytokinetics CYTK Stock Earnings Reports

Q2'26

Est.

$-1.64

Q1'26

Missed

by $0.02

Q4'25

Beat

by $0.06

Q3'25

Missed

by $0.98

Q2'25

Beat

by $0.30

The last earnings report on May 05 showed earnings per share of -166 cents, missing the estimate of -164 cents. With 965.14K shares outstanding, the current market capitalization sits at 10.86B.

View a ticker or compare two or three

Compare

CYTK

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CYTK